Exagen (XGN) Share-based Compensation Growth (3y) (2021 - 2026)
Exagen (XGN) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | -20.63% |
| 10 | Exagen | 158.16 Mn | 133.56 Mn | 12.22 Mn | 0.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07% |
| Mar 31, 2026 | -12.75% |
| Dec 31, 2025 | 260.88% |
| Sep 30, 2025 | 30.62% |
| Jun 30, 2025 | -45.26% |
| Mar 31, 2025 | 53.63% |
| Dec 31, 2024 | 28.50% |
| Sep 30, 2024 | -45.68% |
| Jun 30, 2024 | -24.18% |
| Mar 31, 2024 | -15.36% |
| Dec 31, 2023 | -2.25% |
| Sep 30, 2023 | 3.66% |
| Jun 30, 2023 | 14.77% |
| Mar 31, 2023 | 31.76% |
| Dec 31, 2022 | -68.65% |
| Sep 30, 2022 | -252.52% |
| Jun 30, 2022 | 526.20% |
| Mar 31, 2022 | 112.41% |
| Dec 31, 2021 | -534.67% |